FDA Drug Safety Process Subject To IoM Review Under Agency Initiative
FDA will sponsor an Institute of Medicine study of the agency's drug safety process as part of a broad initiative to strengthen the pre- and post-market evaluation of drugs
FDA will sponsor an Institute of Medicine study of the agency's drug safety process as part of a broad initiative to strengthen the pre- and post-market evaluation of drugs